Bifidobacterium Longum and Its Potential Role in Colorectal Cancer

Seong H, Izutsu R, Osaki M, Okada F. Cancer prevention: Past challenges and future directions. Genes and Environment. 2025;47(1):4. doi:10.1186/s41021-025-00326-y

Hassanpour SH, Dehghani M. Review of cancer from perspective of molecular. Journal of Cancer Research and Practice. 2017;4(4):127–9. doi:10.1016/j.jcrpr.2017.07.001

Karati D, Kumar D. Molecular insight into the apoptotic mechanism of cancer cells: An explicative review. Current Molecular Pharmacology. 2024;17(1):e18761429273223. doi:10.2174/0118761429273223231124072223

Alzahrani SM, Al Doghaither HA, Al-Ghafari AB. General insight into cancer: An overview of colorectal cancer. Molecular and Clinical Oncology. 2021;15(6):271. doi:10.3892/mco.2021.2433

Boutry J, Tissot S, Ujvari B, Capp J-P, Giraudeau M, Nedelcu AM, et al. The evolution and ecology of benign tumors. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2022;1877(1):188643. doi:10.1016/j.bbcan.2021.188643

Sherif ZA, Ogunwobi OO, Ressom HW. Mechanisms and technologies in cancer epigenetics. Frontiers in Oncology. 2025;14:1513654. doi:10.3389/fonc.2024.1513654

Engin MMN, Özen Engin E, Eröz R, Dulger G, Yüce H. Effects of epigenetic regulation on cancer. Journal of Biotechnology and Strategic Health Research. 2021;5(1):1–7. doi:10.34084/bshr.869351

Safi S. Epigenetic Modulation in Cancer: Molecular Mechanisms and Therapeutic Targets–A Review. PJS [Internet]. 2024. doi:10.70389/PJS.100014

Bahrami H, Tafrihi M. Global trends of cancer: The role of diet, lifestyle, and environmental factors. Cancer innovation. 2023;2(4):290–301. doi:10.1002/cai2.76

Sung, H., Filho, A. M., Laversanne, M., Ferlay, J., Siegel, R. L., Soerjomataram, I, et al. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA: A Cancer Journal for Clinicians, 2026:76(4); e70090. doi:10.3322/caac.70090

Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przybyłowicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers. 2021;13(9):2025. doi:10.3390/cancers13092025

Ahmed M. Colon cancer: A clinician’s perspective in 2019. Gastroenterology Research. 2020;13(1):1. doi: 10.14740/gr1239

Chilimoniuk Z, Gładysz K, Moniczewska N, Chawrylak K, Pelc Z, Mlak R. The Role of epigenetic biomarkers as diagnostic, predictive and prognostic factors in colorectal cancer. Cancers. 2025;17(16):2632. doi:10.3390/cancers17162632

Fazeli MS, Keramati MR. Rectal cancer: A review. Medical Journal of the Islamic Republic of Iran. 2015;29:171.

Alrushaid N, Khan FA, Al-Suhaimi E, Elaissari A. Progress and perspectives in colon cancer pathology, diagnosis, and treatments. Diseases. 2023;11(4):148. doi:10.3390/diseases11040148

Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, et al. Colorectal cancer. Nature Reviews Disease Primers. 2015;1(1):15065. doi:10.1038/nrdp.2015.65

Abedizadeh R, Majidi F, Khorasani HR, Abedi H, Sabour D. Colorectal cancer: A comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer and Metastasis Reviews. 2024;43(2):729–53. doi:10.1007/s10555-023-10158-3

Adebayo AS, Agbaje K, Adesina SK, Olajubutu O. Colorectal cancer: Disease process, current treatment options, and future perspectives. Pharmaceutics. 2023;15(11):2620. doi:10.3390/pharmaceutics15112620

Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. International journal of molecular sciences. 2017;18(1):197. doi:10.3390/ijms18010197

Shaikh S, Shete A, Doijad R. Formulation and evaluation pharmaceutical aqueous gel of powdered guava leaves for mouth ulcer treatment. PharmaTutor. 2018;6(4):32–8. doi:10.29161/PT.v6.i4.2018.32

Esmeeta A, Adhikary S, Dharshnaa V, Swarnamughi P, Maqsummiya ZU, Banerjee A, et al. Plant-derived bioactive compounds in colon cancer treatment: An updated review. Biomedicine & Pharmacotherapy. 2022;153:113384. doi: 10.1016/j.biopha.2022.113384

Drago L. Probiotics and colon cancer. Microorganisms. 2019;7(3):66. doi:10.3390/microorganisms7030066

Alam Z, Shang X, Effat K, Kanwal F, He X, Li Y, et al. The potential role of prebiotics, probiotics, and synbiotics in adjuvant cancer therapy especially colorectal cancer. Journal of Food Biochemistry. 2022;46(10):e14302. doi:10.1111/jfbc.14302

Tegegne BA, Abebaw D, Teffera ZH, Fenta A, Belew H, Belayneh M, et al. Microbial therapeutics in cancer: translating probiotics, prebiotics, synbiotics, and postbiotics from mechanistic ınsights to clinical applications: A topical review. The FASEB Journal. 2025;39(20):e71146. doi: 10.1096/fj.202502118R

Smolinska S, Popescu F-D, Zemelka-Wiacek M. A review of the influence of prebiotics, probiotics, synbiotics, and postbiotics on the human gut microbiome and intestinal integrity. Journal of Clinical Medicine. 2025;14(11):3673. doi:10.3390/jcm14113673

Pandey K, Naik S, Vakil B. Probiotics, prebiotics and synbiotics-a review. Journal of Food Science and Technology. 2015;52(12):7577–87. doi: 10.1007/s13197-015-1921-1

Shokryazdan P, Faseleh Jahromi M, Liang JB, Ho YW. Probiotics: from isolation to application. Journal of the American College of Nutrition. 2017;36(8):666–76. doi:10.1080/07315724.2017.1337529

Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Advances in Nutrition. 2019;10:S49–S66. doi: 10.1093/advances/nmy063

Śliżewska K, Markowiak-Kopeć P, Śliżewska W. The role of probiotics in cancer prevention. Cancers. 2021;13(1):20. doi:10.3390/cancers13010020

Stavropoulou E, Bezirtzoglou E. Probiotics in medicine: a long debate. Frontiers in Immunology. 2020;11:2192. doi:10.3389/fimmu.2020.02192

Li Q, Li Y, Wang Y, Xu L, Guo Y, Wang Y, et al. Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12. Oncoimmunology. 2021;10(1):1868122. doi:10.1080/2162402X.2020.1868122

Molska M, Reguła J. Potential mechanisms of probiotics action in the prevention and treatment of colorectal cancer. Nutrients. 2019;11(10):2453. doi:10.3390/nu11102453

Eslami M, Yousefi B, Kokhaei P, Hemati M, Nejad ZR, Arabkari V, et al. Importance of probiotics in the prevention and treatment of colorectal cancer. Journal of Cellular Physiology. 2019;234(10):17127–43. doi:10.1002/jcp.28473

34. Wei H, Chen L, Lian G, Yang J, Li F, Zou Y, et al. Antitumor mechanisms of bifidobacteria. Oncology Letters. 2018;16(1):3–8. doi:10.3892/ol.2018.8692

Sharma D, Gajjar D, Seshadri S. Understanding the role of gut microfloral bifidobacterium in cancer and its potential therapeutic applications. Microbiome Research Reports. 2023;3(1):3. doi: 10.20517/mrr.2023.51

Parisa A, Roya G, Mahdi R, Shabnam R, Maryam E, Malihe T. Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis. PloS One. 2020;15(5):e0232930. doi:10.1371/journal.pone.0232930

Sadeghpour Heravi F, Hu H. Bifidobacterium: host–microbiome interaction and mechanism of action in preventing common gut-microbiota-associated complications in preterm infants: a narrative review. Nutrients. 2023;15(3):709. doi:10.3390/nu15030709

Bocchio F, Mancabelli L, Milani C, Lugli GA, Tarracchini C, Longhi G, et al. Compendium of Bifidobacterium-based probiotics: characteristics and therapeutic impact on human diseases. Microbiome Research Reports. 2024;4(1):2. doi: 10.20517/mrr.2024.52

Yoon Y, Kim G, Jeon B-N, Fang S, Park H. Bifidobacterium strain-specific enhances the efficacy of cancer therapeutics in tumor-bearing mice. Cancers. 2021;13(5):957. doi:10.3390/cancers13050957.

Zhang Y, Cao T, Wang Y, Yang R, Han Y, Li S, et al. Effects of Viable and Heat-Inactivated Bifidobacterium longum D42 on Proliferation and Apoptosis of HT-29 Human Colon Cancer Cells. Foods. 2024;13(6):958. doi:10.3390/foods13060958

Rätsep M, Kilk K, Zilmer M, Kuusik S, Kuus L, Vallas M, et al. Investigation of Effects of Novel Bifidobacterium longum ssp. longum on Gastrointestinal Microbiota and Blood Serum Parameters in a Conventional Mouse Model. Microorganisms. 2024;12(4):840. doi:10.3390/microorganisms12040840

Mills S, Yang B, Smith GJ, Stanton C, Ross RP. Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond. Gut Microbes. 2023;15(1):2186098. doi:10.1080/19490976.2023.2186098

Xiao Y, Huang L, Zhao J, Chen W, Lu W. The gut core microbial species Bifidobacterium longum: Colonization, mechanisms, and health benefits. Microbiological Research. 2025;290:127966. doi:10.1016/j.micres.2024.127966

Wong CB, Odamaki T, Xiao J-z. Beneficial effects of Bifidobacterium longum subsp. longum BB536 on human health: Modulation of gut microbiome as the principal action. Journal of Functional Foods. 2019;54:506–19. doi:10.1016/j.jff.2019.02.002

Shang F, Jiang X, Wang H, Guo S, Kang S, Xu B, et al. Bifidobacterium longum suppresses colorectal cancer through the modulation of intestinal microbes and immune function. Frontiers in Microbiology. 2024;15:1327464. doi:10.3389/fmicb.2024.1327464

Pei B, Peng S, Huang C, Zhou F. Bifidobacterium modulation of tumor immunotherapy and its mechanism. Cancer Immunology, Immunotherapy. 2024;73(5):94.doi:10.1007/s00262-024-03665-x

Shi S, Zhang Q, Sang Y, Ge S, Wang Q, Wang R, et al. Probiotic Bifidobacterium longum BB68S improves cognitive functions in healthy older adults: A randomized, double-blind, placebo-controlled trial. Nutrients. 2023;15(1):51. doi:10.3390/nu1501005

Yao S, Zhao Z, Wang W, Liu X. Bifidobacterium longum: protection against inflammatory bowel disease. Journal of Immunology Research. 2021;2021(1):8030297. doi:10.1155/2021/8030297

Shimizu Y, Isoda K, Taira Y, Taira I, Kondoh M, Ishida I. Anti-tumor effect of a recombinant Bifidobacterium strain secreting a claudin-targeting molecule in a mouse breast cancer model. European Journal of Pharmacology. 2020;887:173596. doi:10.1016/j.ejphar.2020.173596

Yue F, Zeng X, Wang Y, Fang Y, Yue M, Zhao X, et al. Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis. BMC Microbiology. 2024;24(1):8. doi:10.1186/s12866-023-03152-w

Zhang Y, Cao T, Wang Y, Yang R, Han Y, Li S, et al. Effects of viable and heat-inactivated Bifidobacterium longum D42 on proliferation and apoptosis of HT-29 human colon cancer cells. Foods. 2024;13(6):958. doi:10.3390/foods13060958

Liong M-T. Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence. International Journal of Molecular Sciences. 2008;9(5):854–63. doi: 10.3390/ijms9050854